In our research, the serum Fibulin-1 levels were significantly increased in HCC patients than in healthy controls, chronic hepatitis B patients and individuals with HBV-induced liver cirrhosis. This evidence concerns the gene FBLN1 and chronic hepatitis B virus infection.